CSIMarket
 
Bioadaptives Inc   (BDPT)
 
Price: $0.0016 $0.00 6.667%
Day's High: $0.0017000000225380063 Week Perf: 6.67 %
Day's Low: $ 0.00 30 Day Perf: -17.1 %
Volume (M): 3,891,933 52 Wk High: $ 0.07
Volume (M$): $ 0 52 Wk Avg: $0.02
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 281
 Employees 1
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Bioadaptives Inc is a technology-based company that focuses on developing and commercializing innovative solutions for health and wellness. The company specializes in the development of patented and proprietary ingredients that are designed to improve various aspects of human health and well-being. They primarily focus on natural ingredients derived from plants and other organic sources.

Bioadaptives Inc aims to provide sustainable and effective solutions to promote better health, enhance physical and cognitive performance, and support overall wellness. Their products are developed using advanced scientific research and undergo rigorous testing to ensure safety and efficacy.

The company also focuses on bioavailability and aims to develop ingredients that are easily absorbed by the body, maximizing their potential benefits. They work closely with experts in the fields of biotechnology, nutrition, and health sciences to develop and commercialize their products.

Overall, Bioadaptives Inc strives to revolutionize the health and wellness industry by providing innovative and natural solutions that can improve the quality of life for individuals.


   Company Address: 2620 Regatta Drive Las Vegas 89128 NV
   Company Phone Number: 659-8829   Stock Exchange / Ticker: BDPT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALDX        1.49% 
AMRN   -1.23%    
CNSP   -12.5%    
LPCN   -2.64%    
OCUL   -4.77%    
TNXP   -8.42%    
• View Complete Report
   



Clinical Study

BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia

Published Mon, Nov 25 2024 2:15 PM UTC

BioAdaptives, Inc. Achieves Milestone with IRB Approval for Zeranovia Clinical Trial In a significant advancement for the field of weight management and health sciences, BioAdaptives, Inc. (OTC: BDPT) announced the approval of its human clinical trial for Zeranovia, a promising product targeted at facilitating weight management. This crucial endorsement comes from the Insti...

Product Service News

BioAdaptives, Inc. (OTC BDPT), based in Las Vegas, is poised to make a significant impact in the nutritiona...

Published Fri, Nov 22 2024 12:09 AM UTC

BioAdaptives, Inc. Prepares to Revolutionize the Nutritional Marketplace with Innovative Product Launch BioAdaptives, Inc. (OTC: BDPT), based in Las Vegas, is poised to make a significant impact in the nutritional supplements industry with the phased introduction of five groundbreaking products. This strategic movement heralds a new era for the company, marked by the appoint...

Product Service News

BioAdaptives, Inc. Pioneering Innovations Amidst Growing Financial Stability

Published Wed, Nov 13 2024 2:15 PM UTC

In an era where scientific innovation collides with market needs, BioAdaptives, Inc. is taking significant strides to redefine its position within the biotechnology sector. The company recently announced a comprehensive product overhaul designed to align its offerings with contemporary market demands while emphasizing exceptional customer value. This move not only signifies ...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 17.60
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio -
Working Capital Ratio 0.03
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.13 $
Revenues (TTM) 0 $
Cash Flow (TTM) -
Cash -
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 25,561
Net Income per Employee (TTM) -1,130,493
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) 0.14
Asset Turnover Ratio (TTM) 0.18

Profitability Ratios Current
Gross Margin (MRQ) 85 %
Operating Margin (MRQ) -3953.01 %
Net Margin (MRQ) 3677.65 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Bioadaptives Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.